These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10838071)

  • 1. Differential incorporation of 1-beta-D-arabinofuranosylcytosine and 9-beta-D-arabinofuranosylguanine into nuclear and mitochondrial DNA.
    Zhu C; Johansson M; Karlsson A
    FEBS Lett; 2000 Jun; 474(2-3):129-32. PubMed ID: 10838071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute cytotoxicity of arabinofuranosyl nucleoside analogs is not dependent on mitochondrial DNA.
    Curbo S; Johansson M; Balzarini J; Lewis LD; Karlsson A
    Exp Cell Res; 2009 Sep; 315(15):2539-43. PubMed ID: 19481540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arabinosylguanine is phosphorylated by both cytoplasmic deoxycytidine kinase and mitochondrial deoxyguanosine kinase.
    Rodriguez CO; Mitchell BS; Ayres M; Eriksson S; Gandhi V
    Cancer Res; 2002 Jun; 62(11):3100-5. PubMed ID: 12036920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 9-beta-D-arabinofuranosylguanine on mitochondria in CEM T-lymphoblast leukemia cells.
    Curbo S; Zhivotovsky B; Johansson M; Karlsson A
    Biochem Biophys Res Commun; 2003 Aug; 307(4):942-7. PubMed ID: 12878202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of guanine-β-D-arabinofuranoside and deoxyguanosine to triphosphates by a common pathway blocks T lymphoblasts at different checkpoints.
    Leanza L; Miazzi C; Ferraro P; Reichard P; Bianchi V
    Exp Cell Res; 2010 Dec; 316(20):3443-53. PubMed ID: 20603113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of 4'-thio-beta-D-arabinofuranosylcytosine and its analogs by human deoxycytidine kinase.
    Someya H; Shaddix SC; Tiwari KN; Secrist JA; Parker WB
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1314-22. PubMed ID: 12604712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of 4'-thio-beta-D-arabinofuranosylcytosine in CEM cells.
    Parker WB; Shaddix SC; Rose LM; Waud WR; Shewach DS; Tiwari KN; Secrist JA
    Biochem Pharmacol; 2000 Dec; 60(12):1925-32. PubMed ID: 11108809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced cytotoxicity of nucleoside analogs by overexpression of mitochondrial deoxyguanosine kinase in cancer cell lines.
    Zhu C; Johansson M; Permert J; Karlsson A
    J Biol Chem; 1998 Jun; 273(24):14707-11. PubMed ID: 9614068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual mechanisms of 9-beta-D-arabinofuranosylguanine resistance in CEM T-lymphoblast leukemia cells.
    Curbo S; Zhu C; Johansson M; Balzarini J; Karlsson A
    Biochem Biophys Res Commun; 2001 Jul; 285(1):40-5. PubMed ID: 11437369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential metabolism of 9-beta-D-arabinofuranosylguanine in human leukemic cells.
    Shewach DS; Mitchell BS
    Cancer Res; 1989 Dec; 49(23):6498-502. PubMed ID: 2819707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNAi depletion of deoxycytidine and deoxyguanosine kinase in human leukemic CEM cells.
    Fyrberg A; Albertioni F; Lotfi K
    Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):712-9. PubMed ID: 18600530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of anticancer nucleoside analogs by human mitochondrial deoxyguanosine kinase.
    Zhu C; Johansson M; Permert J; Karlsson A
    Biochem Pharmacol; 1998 Oct; 56(8):1035-40. PubMed ID: 9776315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporation of nucleoside analogs into nuclear or mitochondrial DNA is determined by the intracellular phosphorylation site.
    Zhu C; Johansson M; Karlsson A
    J Biol Chem; 2000 Sep; 275(35):26727-31. PubMed ID: 10827186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of arabinosyl guanine by a mitochondrial enzyme of bovine liver.
    Lewis RA; Link L
    Biochem Pharmacol; 1989 Jun; 38(12):2001-6. PubMed ID: 2545209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low level of mitochondrial deoxyguanosine kinase is the dominant factor in acquired resistance to 9-beta-D-arabinofuranosylguanine cytotoxicity.
    Lotfi K; Månsson E; Peterson C; Eriksson S; Albertioni F
    Biochem Biophys Res Commun; 2002 May; 293(5):1489-96. PubMed ID: 12054684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bystander effects of nucleoside analogs phosphorylated in the cytosol or mitochondria.
    Sanda A; Zhu C; Johansson M; Karlsson A
    Biochem Biophys Res Commun; 2001 Oct; 287(5):1163-6. PubMed ID: 11587545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced drug incorporation into DNA and antiapoptosis as the crucial mechanisms of resistance in a novel nelarabine-resistant cell line.
    Yamauchi T; Uzui K; Nishi R; Shigemi H; Ueda T
    BMC Cancer; 2014 Jul; 14():547. PubMed ID: 25070259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of intracellular metabolism of cytosine arabinoside in acute myeloid leukemia by granulocyte-macrophage colony-stimulating factor.
    Reuter C; Auf der Landwehr U; Schleyer E; Zühlsdorf M; Ameling C; Rolf C; Wörmann B; Büchner T; Hiddemann W
    Leukemia; 1994 Feb; 8(2):217-25. PubMed ID: 8309245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of deoxycytidine kinase in an in vitro model for AraC- and DAC-resistance: substrate-enzyme interactions with deoxycytidine, 1-beta-D-arabinofuranosylcytosine and 5-aza-2'-deoxycytidine.
    Stegmann AP; Honders MW; Kester MG; Landegent JE; Willemze R
    Leukemia; 1993 Jul; 7(7):1005-11. PubMed ID: 7686601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The enantioselectivity of the cellular deoxynucleoside kinases.
    Wang J; Chattopadhyaya J; Eriksson S
    Nucleosides Nucleotides; 1999; 18(4-5):807-10. PubMed ID: 10432682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.